Skip to main content
. Author manuscript; available in PMC: 2014 May 28.
Published in final edited form as: Endocr Pract. 2013 Jul-Aug;19(4):663–668. doi: 10.4158/EP12318.OR

Table 3.

Summary of GAD65Ab characteristics in samples with high GAD65Ab titer.

Sample (#) Inhibition by
rFab b78 (%)
Inhibition by rFab
b96.11 (%)
Enzyme inhibition
(%)
GAD65Ab titer
(U/ml)
1 26 (±2) 28 (±4) 39 (±4) 250000
2 0 (±5) 0 (±5) 29 (±1) 10000
3 4 (±0) 38 (±3) 36 (±7) 10000
4 16 (±0) 13 (±2) 45 (±3) 8000
5 3 (±2) 56 (±5) 50 (±7) 4000
6 0 (±2) 26 (±0) 13 (±1) 3000
7 1 (±3) 75 (±5) 20 (±5) 2000
8 4 (±4) 26 (±2) 18 (±9) 8000
9 42 (±2) 7 (±6) 55 (±6) 250000
10 34 (±4) 7 (±4) 34 (±5) 80000